Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Novel treatment can effectively inhibit development of GVHD in mice, study shows

Novel treatment can effectively inhibit development of GVHD in mice, study shows

Roswell Park study provides new insights into gene mutations that can lead to cancer

Roswell Park study provides new insights into gene mutations that can lead to cancer

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

NCCN publishes new easy-to-understand patient education resources focused on brain cancer

Northwestern Medicine scientists identify targeted molecular therapy that halts childhood leukemia

Northwestern Medicine scientists identify targeted molecular therapy that halts childhood leukemia

Study shows promising results for treating lymphoma patients with immune cell therapy

Study shows promising results for treating lymphoma patients with immune cell therapy

Yoga during active treatment can provide QOL benefits for pediatric cancer patients and parents

Yoga during active treatment can provide QOL benefits for pediatric cancer patients and parents

Scientists reveal chemical process behind anti-cancer properties of spicy pepper plant

Scientists reveal chemical process behind anti-cancer properties of spicy pepper plant

Persistent infection in infant reveals mutation that helps bacteria tolerate antibiotic therapy

Persistent infection in infant reveals mutation that helps bacteria tolerate antibiotic therapy

Researchers identify possible treatment targets for myelodysplasia syndromes

Researchers identify possible treatment targets for myelodysplasia syndromes

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Fred Hutch’s new Evergreen Fund to promote commercialization of research into lifesaving therapies

Combination of diabetes and hypertension drugs can effectively treat cancer

Combination of diabetes and hypertension drugs can effectively treat cancer

UC researchers uncover obesity-related protein's role in leukemia development

UC researchers uncover obesity-related protein's role in leukemia development

FDA awards accelerated approval to new ovarian cancer drug

FDA awards accelerated approval to new ovarian cancer drug

New clinical study for children with AML aims to kill leukemia cells and minimize cardiac damage

New clinical study for children with AML aims to kill leukemia cells and minimize cardiac damage

Mayo Clinic creates genetic test to help guide diagnosis, treatment of lymphoma patients

Mayo Clinic creates genetic test to help guide diagnosis, treatment of lymphoma patients

Newborns with CMV may have increased risk of developing acute lymphocytic leukemia

Newborns with CMV may have increased risk of developing acute lymphocytic leukemia

Scientists isolate and characterize therapy-resistant dormant leukemia cells

Scientists isolate and characterize therapy-resistant dormant leukemia cells

Scientists develop first functional biological pacemaker from human stem cells

Scientists develop first functional biological pacemaker from human stem cells

New technology that increases Natural Killer cells to stop cancers gets licensed

New technology that increases Natural Killer cells to stop cancers gets licensed

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.